← Back to Search

1 for High Cholesterol

Phase 4
Waitlist Available
Research Sponsored by Provident Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through end of treatment
Awards & highlights

Study Summary

The objectives of this study are to assess the effects of 4 g/d P-OM3, compared with placebo, on LDL-C and other aspects of the fasting lipid profile in subjects with primary hypercholesterolemia.

Eligible Conditions
  • High Cholesterol

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to end of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to end of treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The variable will be the percent change from baseline in LDL-C during each treatment.
Secondary outcome measures
Body Weight Changes

Trial Design

2Treatment groups
Experimental Treatment
Group I: 2Experimental Treatment2 Interventions
Placebo for the first six weeks of treatment. P-OM3 for the second six weeks of treatment.
Group II: 1Experimental Treatment2 Interventions
P-OM3 for the first six weeks of treatment. Placebo for the second six weeks of treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

GlaxoSmithKlineIndustry Sponsor
4,753 Previous Clinical Trials
8,069,656 Total Patients Enrolled
2 Trials studying High Cholesterol
112 Patients Enrolled for High Cholesterol
Provident Clinical ResearchLead Sponsor
14 Previous Clinical Trials
1,157 Total Patients Enrolled
Kevin C. Maki, PhDStudy DirectorProvident Clinical Research
3 Previous Clinical Trials
69 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
2010. "Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00746811.
All > Cholesterol
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top